Liposonix+ is a non-surgical, FDA-approved treatment that uses high-intensity focused ultrasound to permanently destroy unwanted and stubborn fat. The treatment process can be customisable to address specific “problem” areas. Backed by over 10 years of research and testing, it has little to no downtime and is a good alternative to liposuction.
How it works
The Liposonix+ system is highly versatile, allowing control over precisely how and where energy is delivered for a customised treatment.
With many other non-invasive fat reduction technologies such as radiofrequency and lasers, energy is highly absorbed or scattered near the skin surface, thereby limiting penetration into subcutaneous fat tissue and delivering only temporary results. Ultrasound energy, on the other hand, can be used to penetrate through the skin layers and into the targeted fat tissue without harming skin or surrounding tissues. Other ultrasound body contouring technologies often use low-intensity, low-frequency, or unfocused energy which can require multiple treatments and lead to unpredictable results. The versatility of Liposonix+ system enables precise control of high-intensity focused ultrasound energy to non-invasively destroy targeted subcutaneous fat and deliver uniform, predictable results after a treatment.
If you are close to your ideal shape, but need a little help getting there, Liposonix+ may be for you. Results are typically seen in 8 to 12 weeks (which is equivalent to the time needed for your body to naturally process the treated fat). Liposonix+ is not liposuction or surgery, is not a replacement for a healthy lifestyle and exercise, and is not a way to lose weight. It can be considered as an alternative to help you slim that last inch and hit your personal body goals.
The Ministry of Health of Singapore does not allow the publishing of before and after photographs and patient testimonials in advertising materials. If you visit our clinics for more information, we will be happy to show you more photographs and pictures of our patients.